In this special report, DSN takes a look at the collaborative solutions the industry is undertaking to keep patients safe as deaths from opioid abuse and misuse continue to rise.
On a per-share basis, the San Francisco-based company reported net income of $4.33. Earnings, adjusted for one-time gains and costs, were $3.41 per share.
Industry leaders say shortening the perceived distance between the pharmacy and front of store is imperative to ensuring the entire retail operation can act as an effective, integrated health destination.
Adam Wampler joins the Seattle-based company as senior vice president of operations from Albertsons, where he was senior vice president of operations for Northern California.
